Tyvaso DPI

United Therapeutics Corporation🇺🇸 United States

FDA Page

Effective Date: Nov 20, 2025
Approval ID: ddc3d400-bcb3-4b09-aae2-0768b10a5b0f
Products: 19 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI (treprostinil) inhalation powder, for oral inhalation use Initial U.S. Approval: 2002

Quick Stats

Total Products19

Labelers2

Label Sections54

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.